HS-20152
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HS-20152, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of HS-20152 in Healthy Participants [Phase 1]